http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/ News About Tech, Money and Innovation Wed, 25 Nov 2009 06:07:42 +0000 http://wordpress.org/?v=2.8.5 hourly 1 http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/comment-page-1/#comment-800376 Life-science briefing: Friday, March 21, 2008 » VentureBeat Thu, 27 Mar 2008 02:08:01 +0000 http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/#comment-800376 [...] would make it possible to get drugs into the bloodstream without injections. A few others include Corium, which swallowed StrataGent; Zosano Pharma; and Glide Pharma. This sort of technology would be ideal for biotech drugs such as [...] [...] would make it possible to get drugs into the bloodstream without injections. A few others include Corium, which swallowed StrataGent; Zosano Pharma; and Glide Pharma. This sort of technology would be ideal for biotech drugs such as [...]

]]> http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/comment-page-1/#comment-664344 VentureBeat » Life sciences briefing: Tuesday, Dec. 4, 2007 Wed, 05 Dec 2007 01:38:03 +0000 http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/#comment-664344 [...] CardioMems’ first product is a sensor that can detects the pressure within an aneurysm, a weakened section of an arterial wall that is susceptible to rupture. We previously covered the company here. [...] [...] CardioMems’ first product is a sensor that can detects the pressure within an aneurysm, a weakened section of an arterial wall that is susceptible to rupture. We previously covered the company here. [...]

]]> http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/comment-page-1/#comment-559400 VentureBeat » Life sciences briefing: Monday, Oct. 1, 2007 Mon, 01 Oct 2007 20:05:55 +0000 http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/#comment-559400 [...] such as that of Stratagent, which recently merged with Corium (our coverage in the first item here). For more stories on VentureBeat Life Sciences, click here.Tagged biotechnology, brain cancer, [...] [...] such as that of Stratagent, which recently merged with Corium (our coverage in the first item here). For more stories on VentureBeat Life Sciences, click here.Tagged biotechnology, brain cancer, [...]

]]> http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/comment-page-1/#comment-554822 VentureBeat » Osprey Pharma names new CEO Thu, 27 Sep 2007 15:32:45 +0000 http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/#comment-554822 [...] our story about this San Francisco company in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story about this San Francisco company in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]> http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/comment-page-1/#comment-554808 VentureBeat » Corium acquires Stratagent, raises $25.1M for “transdermal” drugs Thu, 27 Sep 2007 15:30:43 +0000 http://venturebeat.com/2007/09/27/life-sciences-briefing-thursday-sept-27-2007/#comment-554808 [...] our story about these companies in Menlo Park, Calif., and San Jose, Calif., in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...] [...] our story about these companies in Menlo Park, Calif., and San Jose, Calif., in today’s daily briefing at VentureBeat Life Sciences. Tagged N/A VentureBeat [...]

]]>